Koen Kas

Koen Kas

Healthcare Futurist, Digital Health Pioneer, & Strategic Visionary

Core Intelligence Domain: Healthcare Innovation & Digital Health
Location: Belgium | Languages: English, Dutch
Representation: Represented globally by PSpeakers Global Intelligence

Koen Kas is a globally recognised healthcare futurist, digital health pioneer, and visionary biotech entrepreneur who is fundamentally redefining the future of medicine. As the driving force behind the transition from reactive “sickcare” to proactive, predictive healthcare, Professor Kas empowers global enterprises, pharmaceutical giants, and health tech innovators to integrate digital disruption, genomics, and strategic foresight into their core operational frameworks. His proprietary insights bridge the gap between complex biological sciences and consumer-centric digital innovations, enabling C-suite leaders to navigate the rapidly evolving healthcare landscape with agility and purpose.

Professional Trajectory & Global Leadership

Professor Kas has built a distinguished career at the intersection of molecular oncology, biotechnology, and digital health. He serves as the Founding CEO of HealthSkouts, a premier digital health foresight and innovation agency that assists organisations in harnessing data and disruptive technologies to create sustainable health solutions. His strategic advisory roles extend to numerous biotech and digital health startups, where he provides critical oversight on scaling innovations and entering global markets.

Academically grounded, he holds a professorship in Molecular Oncology at Ghent University and chairs the scientific advisory board of several prominent life sciences funds. Previously, he served as the Chief Scientific Officer (CSO) of Oncology at ThromboGenics (now Oxurion), where he spearheaded the spin-out of Oncurious, further cementing his reputation as a formidable life sciences executive. His extensive background in biomarker discovery and drug development provides him with an unparalleled foundation to forecast where clinical medicine and digital technology will converge.

Proprietary Frameworks & Literary Contributions

A central pillar of Koen Kas’s thought leadership is his proprietary framework aimed at shifting the global medical paradigm. He is the author of two highly acclaimed books that serve as essential reading for healthcare executives and policymakers:

• Sick No More: A groundbreaking manifesto detailing the impending shift towards a world where illness is predicted and prevented before it manifests, driven by genomics, wearable technology, and artificial intelligence.
• Your Guide to Delight: An exploration into how the healthcare industry can adopt the customer-centric models of the tech and hospitality sectors, focusing on creating frictionless, delightful experiences for patients and providers alike.

Core Speaking Themes & Strategic Briefings

As a highly sought-after global keynote speaker, Koen Kas delivers immersive, data-rich presentations tailored to executive boards, medical associations, and technology summits. His key speaking topics include:

• The End of “Sickcare”: How predictive analytics, AI, and continuous biological monitoring are rendering traditional reactive medicine obsolete.
• Digital Therapeutics and the Future Pharma Landscape: Strategic insights into how software, data, and algorithms are becoming the new blockbuster drugs.
• Designing “Delight” in Healthcare: Frameworks for transforming patient journeys from clinical and cumbersome to seamless and empowering.
• The Convergence of Biology and Technology: A deep dive into the synergistic power of genomics, synthetic biology, and machine learning.
• Foresight for C-Suite Leaders in Life Sciences: Actionable strategies for future-proofing pharmaceutical and MedTech portfolios against disruptive challengers.

Key Takeaways

• Strategic Foresight: Delivers actionable roadmaps for navigating the transition from reactive disease management to proactive health preservation.
• Interdisciplinary Expertise: Combines deep scientific rigour (molecular oncology) with cutting-edge digital health innovation (AI, wearables, digital therapeutics).
• Consumer-Centric Transformation: Provides proprietary frameworks to help healthcare organisations redesign their services for maximum patient “delight” and engagement.
• High-Level Advisory: Offers board-level intelligence on emerging biotech trends, investment opportunities, and digital disruption.